Glycated albumin levels are associated with adverse stroke outcomes in patients with acute ischemic stroke in China
{{output}}
Background and aim: Glycated albumin (GA) is a biomarker monitoring glycemia 2-4 weeks before stroke onset. This study was designed to explore the association between GA levels with poststroke outcomes in patients with acute isch... ...
